A novel de novo germline mutation Glu40Lys in AKT3 causes megalencephaly with growth hormone deficiency

Am J Med Genet A. 2017 Apr;173(4):1071-1076. doi: 10.1002/ajmg.a.38099. Epub 2017 Feb 12.

Abstract

Germline or somatic gain-of-function mutations in the v-akt murine thymoma viral oncogene homolog 3 (AKT3) have been reported to cause syndromic megalencephaly. We describe a novel germline mutation, p.Glu40Lys, in AKT3. Phenotypically, the patient presented with megalencephaly with hypotonia, apparent connective tissue laxity, and growth hormone (GH) deficiency. To our knowledge, this is the first instance of a patient with megalencephaly with GH deficiency, harboring a germline de novo mutation in AKT3. © 2017 Wiley Periodicals, Inc.

Keywords: AKT3; growth hormone deficiency; megalencephaly.

Publication types

  • Case Reports

MeSH terms

  • Amino Acid Sequence
  • Asian People
  • Base Sequence
  • Child, Preschool
  • Connective Tissue / metabolism
  • Connective Tissue / pathology
  • Exome
  • Gene Expression
  • Germ-Line Mutation*
  • Growth Hormone / deficiency*
  • Growth Hormone / genetics
  • High-Throughput Nucleotide Sequencing
  • Humans
  • Male
  • Megalencephaly / diagnosis
  • Megalencephaly / ethnology
  • Megalencephaly / genetics*
  • Megalencephaly / pathology
  • Muscle Hypotonia / diagnosis
  • Muscle Hypotonia / ethnology
  • Muscle Hypotonia / genetics*
  • Muscle Hypotonia / pathology
  • Phenotype
  • Proto-Oncogene Proteins c-akt / genetics*
  • Proto-Oncogene Proteins c-akt / metabolism

Substances

  • Growth Hormone
  • AKT3 protein, human
  • Proto-Oncogene Proteins c-akt